Here are relevant reports on : oncology-diagnostics-market
-
Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029
The global advanced visualization market, valued at US$3.36 billion in 2023, stood at US$3.78 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$6.55 billion by the end of the period. Technological advancements in advanced visualization tools, the rising need for early detection of diseases, and the growing support from government & private organizations are key factors driving the market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
US Enteral Feeding Devices Market by Type (Nasogastric Tubes, Administration Sets, Nasal Feeding, Nasoduodenal, Syringes, Connectors), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The US enteral feeding device market, valued at US$1.13 billion in 2025, stood at US$1.19 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2032, culminating in a forecasted valuation of US$1.70 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031
The Middle East & Africa electrosurgery market, valued at USD 0.16 billion in 2024, stood at USD 0.17 billion in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2025 to 2031, culminating in a forecasted valuation of USD 0.22 billion by the end of the period. The rise in chronic diseases, an increase in the number of surgeries being performed, the trend of adopting minimally invasive surgeries, the healthcare infrastructure being built, technological progress in energy devices, and medical tourism are all factors that have led to the growth of the Middle East & Africa electrosurgery market.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
ASEAN Infusion Pump Market by Product (Accessories (Dedicated (Volumetric Pumps, Insulin Pumps, Enteral Pumps) & Non-dedicated), Devices (Traditional, Specialty)), Application (Oncology, Diabetes, Pain Management), End User - Global Forecast to 2030
The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Imaging Market by Product (CT, MRI, Imaging Systems, Imaging Reagents, Imaging Software, Accessories), Animal Type (Small, Large), Application (Oncology, Dentistry), Modality (Portable, Stationary), End User, Region - Global Forecast to 2031
The global veterinary imaging market, valued at US$2.13 billion in 2025, stood at US$2.29 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$3.33 billion by the end of the period. This growth is driven by several factors, including an increase in pet ownership, rising spending on animal healthcare, a growing demand for early and accurate diagnosis, and advancements in imaging technologies such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
High Potency APIs Market / HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) & Region - Global Forecast to 2027
The global high potency APIs market growth is primed to transition from $24.5 billion in 2022 to $39.6 billion by 2027, showcasing a strong CAGR of 10.1%. This growth is driven by increasing demand for oncology drugs, advancements in HPAPI manufacturing technologies, and the rising focus on precision medicine.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
The global Photoacoustic imaging market, valued at US$75M in 2023, is forecasted to grow at a 5.5% CAGR, reaching US$80M by 2024 and US$105M by 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User & Region - Global Forecast to 2028
The global radiation dose management market, valued at US$293 million in 2022, stood at US$343 million in 2023 and is projected to advance at a resilient CAGR of 13.8% from 2023 to 2028, culminating in a forecasted valuation of US$654 million by the end of the period. The growth of this market can be attributed to the increasing use of medical imaging modalities due to rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in installation base of radiology equipment, and growing awareness about radiation dose management
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Veterinary CT Scanner Market by Type (Multi Slice CT Scanner, Portable CT Scanner), Animal (Small Animals, Equine, Livestock), Application (Neurology, Oncology, Orthopedic, Traumatology), End User (Animal Hospital, Clinic) - Global Forecast to 2022
The veterinary CT scanner market is expected to reach USD 173.7 Million by 2022 from an estimated USD 122.3 Million in 2017, at a CAGR of 7.3%. The key players in the global veterinary CT scanner market are GE Healthcare (US), Canon, Inc. (Toshiba Medical Systems Corporation) (Japan), Siemens AG (Siemens Healthineers) (Germany), Samsung Electronics Co. Ltd. (NeuroLogica Corporation) (South Korea), Epica Medical Innovation (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Animage, LLC (US), GIN ApS (Denmark), QR s.r.l. (Italy), and 4DDI (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
